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1. Introduction 
Interferon-treated cells are capable of synthesizing 
at least 3 enzymes which are involved in normal cell 
proliferation and anti-viral immunity [l-4]. One of 
these enzymes, interferon- and dsRNA-dependent 
oligoisoadenylate synthetase is responsible for a 
polymerization of ATP resulting in a series of 
(2’ + 5’)-linked oligoadenylic acid 5’-triphosphates. 
The major active species is the trimer, pppA2’p5’A2’- 
p5’A(2-5 A), which is able to inhibit protein synthesis 
in cell-free system at subnanomolarievels [5-7 1. This 
inhibition is mediated by activation of a riboendonu- 
clease which degrades cellular mRNA [g-lo]. In 
[l l] it was shown that (2’ + 5’)-oligoadenylates and 
their bacterial alkaline phosphatase (BAP)-resistant 
cores (which do not contain triphosphate groups) 
were able to inhibit protein synthesis in hypertonically 
permeabilized cells, whereas in cell-free system these 
BAP-treated nucleotides were inactive [7]. 
In another case pppA2’p5’A2’pSfA co-precipitated 
with calcium phosphate showed inhibitory activity on 
protein synthesis in a variety of different cell types 
[12,13]. In [14], inhibition of DNA synthesis by 
(2’ + 5’)-oligoadenylates was observed in lympho- 
cytes stimulated by Con A. 
Here, we report protein synthesis inhibition in 
intact mouse lymphocytes, hepatocytes and bone 
marrow cells by exogenous A2’p5’A, A2’p5’A2’p5’A 
and its bis-phosphoramidate analog. 
2. Materials and methods 
[U-‘4C]Leucine (spec. act. 8880 MBq/mM) was 
obtained from the Institute for Research, Production 
and Application of Radioisotopes (Plague). Medium 
199 (dried) was purchased from Borrough Wellcome 
Co. (London). Fetal calf serum was from Difco Labs. 
(Detroit MI). A2’1~5’A was prepared by successive 
treatment of 3’,5’-0-(tetraisopropyldisiloxane-1,3- 
diyl) adenylyl(2’ + 5’)-2’,3’-di-O-bcnzoyl&V-diben- 
zoyladenosine (2chlorophenyl) ester by ammonia and 
tetrabutyl ammonium fluoride (TBF). A2’p5’A2’p5’A 
was prepared by analogous deblocking of 3’,5’-0-(tetra- 
isopropyldisiloxane-1,3-diyl)-adenylyl-(2’ + 5’)-3’- 
U(tetraisopropyldisiloxane-1-yl)-adenylyl(2’ + 5’)- 
2’,3’-diU-benLoyl-N,,N-dibenzoyladenosine P’,P*-bis- 
(2chlorophcnyl) ester [ 151. The bis-phosphoramidate 
was prepared from the last compound by treatment 
with methanolic ammonia and TBF [ 161. Chromato- 
graphically uniform compounds were used for testing. 
Mouse liver, bone marrow and spleen cells were 
obtained from random bred animals (-14 days-old) 
by in vitro perfusion of organs with incubation 
medium through Ny tal nylon sieve. Released cells 
were layered on 9.25%) (w/v) sucrose buffered with 
30 mM Hepes (pH 7.45) and centrifuged at 1000 rev./ 
min for 7 min at 2°C. The sedimented cells were sus- 
pended at 4-8 X 1 O6 cells/ml in M 199 medium buff- 
ered with 30 mM Hepes and supplemented with 10% 
heat-inactivated fetal calf serum, penicillin (100 U/ml) 
and streptomycin (100 pg/ml). Protein synthesis was 
followed by [U-‘4C]leucine incorporation (0.8 pCi/ 
ml). Cultures of 1 ml were incubated for maximal 
5 h. Aliquots of 0.1 ml were withdrawn and samples 
were processed by a slightly modified method using 
paper pieces of Whatman 3 MM [ 17,181. Aliquots of 
cell suspension were soaked on the paper (2 X 3 cm) 
and strips were immediately immersed into cold 
trichloroacetic acid (7.5%). Washing with cold trichlo- 
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roacetic acid was repeated 4 times and the strips were 
finally washed with ethanol*. Radioactivity of dried 
strips was measured in toluene scintillation liquid. 
3. Results 
The inhibitors tested were added to the culture 
medium to 0.1 PM simultaneously with [U-‘4C]leu- 
tine. The inhibitory effect of protein synthesis in all 
cell types studied was apparent after 1 h incubation. 
After 5 h, protein synthesis was inhibited by 64% in 
lymphocytes, in the presence of A2’p5’A2’p5’A, and 
few % less by its bis-amidate analog (fig.1). 
Practically the same values of protein synthesis 
inhibition were observed in bone marrow cells (fig.2). 
On the other side, the inhibition of protein synthesis 
in hepatocytes reached 45% only (fig.3). 
Levels of 0.1 PM for both inhibitors was found to 
be optimal for observation. A lo-fold decrease of 
concentration led to negligible inhibition of protein 
synthesis (not shown). On the other hand, a lo-fold 
increase of both A2’p5’A2’p5’A and its bis-amidate 
* Washing of samples with hot trichloroacetic acid decreased 
all values (including controls) by 9-lo%, and therefore did 
not affect the degree of inhibition 
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Fig.1. Inhibition of protein synthesis by exogenous 0.1 FM/ 
ml of A2’p5’A2’p5’A (O---O) and its bis-phosphoramidatc 
analog (D-e) in spleen cells. 
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Fig.2. Inhibition of protein synthesis by exogenous 0.1 PM/ 
ml of A2’pS’A2’pS’A (o-0) and its bis-phosphoramidate 
analog (a--~) in bone marrow cells. 
analog caused complete inhibition of protein synthesis 
in all cell types (not shown). 
In the presence of 0.1 PM A2’p5’A, protein syn- 
thesis inhibition was <lo% with all types of cells 
studied (not shown). 
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Fig.3. Inhibition of protein synthesis by exogenous 0.1 PM/ 
ml of A2’pS’A2’p5’A (0 -0) and its bis-phosphoramidate 
analog (Q-a) in hcpatocytes. 
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4. Discussion 
In [13] pppA2’p5’A2’p5’A was shown to be a 
potent inhibitor of protein synthesis in intact cells 
after its uptake was facilitated by calcium co-precipi- 
tation. In the absence of calcium salts, however, dif- 
ferent concentrations of the compound did not affect 
protein synthesis in vivo due to the impermeability of 
ceil membrane. Inhibition of protein synthesis in 
hypertonically permeabilized BHK-2 1 cells by 
pppA2’p5’A2’p5’A and A2’p5’A2’p5’A, which was 
presumably metabolized to active triphosphate deriv- 
ative, was observed in [l 11. 
Our task was to study the influence of exogenous 
(2’ -+ 5’)oligoadenylates on protein synthesis in intact 
mouse cells. Considering that the triphosphate group- 
containing molecule could barely penetrate the intact 
cell membrane, we focused our interest on ‘core’ 
compounds lacking the triphosphate group. 
At first, 3 substances of this type were studied, 
A2’p5’A, A2’pLS1A2’p5’A and its analog containing 
(2’ + 5’)phosphodiester amidate bonds (A2’p5’A2’- 
p5’A bis-amidate). Three types of functionally dif- 
ferent mouse cells, the lymphocytes, hepatocytes and 
bone marrow cells, were selected on the basis of 
assumed differences in cell membrane properties, 
Our findings led us to the conclusions: 
(i) A2’p5’A2’p5’A is able to penetrate the cell mem- 
brane of these intact mouse ; :lls in spite of its 
negatively charged internucleotide bonds. 
(ii) An exogenous level of 0.1 pM/ml of this com- 
pound is about critical to create sufficient intra- 
cellular concentration and cause observable pro- 
tein inhibition. 
Results of parallel experiments withA2’p5’A2’p5’A 
bis-amidate lacking charged internucleotide bonds led 
us to the conclusion that this neutral molecule, despite 
its expected higher ability to penetrate the cell mem- 
brane, is apparently somewhat less efficiently metab- 
olized to the active intracellular inhibitor. 
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